A diabetes drug given in low doses may have anti-ageing effects, US scientists have said following an experiment with mice.
Scientists believe the drug, metformin, may mimic the effects of extreme calorie restriction.
Eating a very low calorie diet is thought to promote healthy ageing, BBC reported.
Rafael de Cabo of the National Institute on Ageing in Baltimore, Maryland, US, said calorie restriction in laboratory animals has shown to increase their lifespan.
However, the human implications of the study were unclear, the researchers said in the journal Nature Communications.
Metformin is a widely prescribed treatment for type-2 diabetes, which occurs mainly in people above the age of 40. It is also used to treat metabolic syndrome, a combination of diabetes, high blood pressure and obesity.
Earlier work has shown that metformin can extend the lifespan of simple organisms like worms, but studies in flies and mammals have given conflicting evidence.
The scientists gave one of two different doses of metformin to middle-aged male mice and found that lower doses increased lifespan by about five percent, and also delayed the onset of age-associated diseases.
But they said the higher dose of metformin was toxic and reduced the lifespan of mice, BBC reported.
De Cabo said further studies were needed to determine if metformin has any effect on human health and lifespan.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
